In particular it has been shown that HRG induces EMT process and cell migration in SK-BR-3 and MCF7 breast cancer cells by binding to the HER-3 receptor and signaling through the PI3K/AKT pathway [85,92,93,94,97,98] (Figure 2B). This evidence concerns the gene AKT1 and breast cancer.